These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35668721)

  • 1. Trifarotene: A Novel Therapeutic Option for Acne.
    Naik PP
    Dermatol Res Pract; 2022; 2022():1504303. PubMed ID: 35668721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Acne Vulgaris With Trifarotene.
    Tan J; Chavda R; Baldwin H; Dreno B
    J Cutan Med Surg; 2023; 27(4):368-374. PubMed ID: 36927117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris.
    Brumfiel CM; Patel MH; Bell KA; Cardis MA
    Ther Clin Risk Manag; 2021; 17():755-763. PubMed ID: 34345173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview on the Management of Atrophic Acne Scars: The Role of Trifarotene as an Adjunct.
    Conte S; Li MK
    Skin Therapy Lett; 2024 Jul; 29(4):1-4. PubMed ID: 38963911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
    Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Topical Retinoid for Acne: Trifarotene 50 μg/g Cream.
    Tan J; Miklas M
    Skin Therapy Lett; 2020 Mar; 25(2):1-2. PubMed ID: 32196146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subject Satisfaction with Trifarotene 50 μg/g Cream in the Treatment of Facial and Truncal Acne Vulgaris: A Case Series.
    Johnson SM; Chavda R; DuBois JC
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1165-1173. PubMed ID: 32623660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.
    Tan J; Thiboutot D; Popp G; Gooderham M; Lynde C; Del Rosso J; Weiss J; Blume-Peytavi U; Weglovska J; Johnson S; Parish L; Witkowska D; Sanchez Colon N; Alió Saenz A; Ahmad F; Graeber M; Stein Gold L
    J Am Acad Dermatol; 2019 Jun; 80(6):1691-1699. PubMed ID: 30802558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trifarotene for the Treatment of Facial and Truncal Acne.
    Bell KA; Brumfiel CM; Haidari W; Boger L
    Ann Pharmacother; 2021 Jan; 55(1):111-116. PubMed ID: 32567361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective RAR agonists for acne vulgaris: A narrative review.
    Kassir M; Karagaiah P; Sonthalia S; Katsambas A; Galadari H; Gupta M; Lotti T; Wollina U; Abdelmaksoud A; Grabbe S; Goldust M
    J Cosmet Dermatol; 2020 Jun; 19(6):1278-1283. PubMed ID: 32100454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trifarotene: A Current Review and Perspectives in Dermatology.
    Cosio T; Di Prete M; Gaziano R; Lanna C; Orlandi A; Di Francesco P; Bianchi L; Campione E
    Biomedicines; 2021 Feb; 9(3):. PubMed ID: 33652835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trifarotene 0.005% Cream in the Treatment of Facial and Truncal Acne Vulgaris in Patients with Skin of Color: a Case Series.
    Del Rosso JQ; Lain E; York JP; Alexis A
    Dermatol Ther (Heidelb); 2022 Sep; 12(9):2189-2200. PubMed ID: 35994159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUPPLEMENT INDIVIDUAL ARTICLES: Update on Truncal Acne: A Review of Treatments for a Neglected Disease and the Re-Emergence of Tazarotene.
    Issa N; Draelos Z; Tanghetti E; Kircik L
    J Drugs Dermatol; 2022 Dec; 21(12):SF3446185-SF34461814. PubMed ID: 36468963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trifarotene: First Approval.
    Scott LJ
    Drugs; 2019 Nov; 79(17):1905-1909. PubMed ID: 31713811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.
    Aubert J; Piwnica D; Bertino B; Blanchet-Réthoré S; Carlavan I; Déret S; Dreno B; Gamboa B; Jomard A; Luzy AP; Mauvais P; Mounier C; Pascau J; Pelisson I; Portal T; Rivier M; Rossio P; Thoreau E; Vial E; Voegel JJ
    Br J Dermatol; 2018 Aug; 179(2):442-456. PubMed ID: 29974453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomics Analysis Indicates Trifarotene Reverses Acne-Related Gene Expression Changes.
    Dreno B; Chavda R; Julia V; Khammari A; Blanchet-Réthoré S; Krishnaswamy JK
    Front Med (Lausanne); 2021; 8():745822. PubMed ID: 34746181
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in Topical Management of Adolescent Facial and Truncal Acne: A Phase 3 Pooled Analysis of Safety and Efficacy of Trifarotene 0.005% Cream.
    Eichenfield L; Kwong P; Lee S; Krowchuk D; Arekapudi K; Hebert A
    J Drugs Dermatol; 2022 Jun; 21(6):582-586. PubMed ID: 35674762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update: Mechanisms of Topical Retinoids in Acne.
    Dreno B; Kang S; Leyden J; York J
    J Drugs Dermatol; 2022 Jul; 21(7):734-740. PubMed ID: 35816067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoids in Acne Management: Review of Current Understanding, Future Considerations, and Focus on Topical Treatments.
    Chien A
    J Drugs Dermatol; 2018 Dec; 17(12):s51-55. PubMed ID: 30586483
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.